Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Capital Expenditures (2018 - 2025)

Historic Capital Expenditures for Bio (TELA) over the last 8 years, with Q3 2025 value amounting to $211000.0.

  • Bio's Capital Expenditures rose 7295.08% to $211000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $621000.0, marking a year-over-year decrease of 3322.58%. This contributed to the annual value of $989000.0 for FY2024, which is 6186.58% up from last year.
  • Per Bio's latest filing, its Capital Expenditures stood at $211000.0 for Q3 2025, which was up 7295.08% from $114000.0 recorded in Q2 2025.
  • Bio's 5-year Capital Expenditures high stood at $336000.0 for Q1 2022, and its period low was $22000.0 during Q1 2021.
  • Its 5-year average for Capital Expenditures is $181894.7, with a median of $200000.0 in 2022.
  • Per our database at Business Quant, Bio's Capital Expenditures soared by 142727.27% in 2022 and then crashed by 8947.37% in 2025.
  • Bio's Capital Expenditures (Quarter) stood at $289000.0 in 2021, then crashed by 84.08% to $46000.0 in 2022, then surged by 345.65% to $205000.0 in 2023, then rose by 28.78% to $264000.0 in 2024, then decreased by 20.08% to $211000.0 in 2025.
  • Its Capital Expenditures stands at $211000.0 for Q3 2025, versus $114000.0 for Q2 2025 and $32000.0 for Q1 2025.